Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 4
2004 12
2005 7
2006 6
2007 7
2008 5
2009 4
2010 9
2011 4
2012 7
2013 7
2014 7
2015 3
2016 6
2017 3
2018 8
2019 11
2020 11
2021 4
2022 12
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

129 results

Results by year

Filters applied: . Clear all
Page 1
An ADAM17 selective inhibitor promotes glucose uptake by activating AMPK.
Toma T, Miyakawa N, Tateishi M, Todaka M, Kondo T, Fujita M, Otsuka M, Araki E, Tateishi H. Toma T, et al. Among authors: kondo t. J Pharmacol Sci. 2024 Jan;154(1):37-46. doi: 10.1016/j.jphs.2023.11.005. Epub 2023 Dec 1. J Pharmacol Sci. 2024. PMID: 38081682 Free article.
A consensus statement from the Japan Diabetes Society (JDS): a proposed algorithm for pharmacotherapy in people with type 2 diabetes.
Bouchi R, Kondo T, Ohta Y, Goto A, Tanaka D, Satoh H, Yabe D, Nishimura R, Harada N, Kamiya H, Suzuki R, Yamauchi T. Bouchi R, et al. Among authors: kondo t. Diabetol Int. 2022 Dec 23;14(1):1-14. doi: 10.1007/s13340-022-00605-x. eCollection 2023 Jan. Diabetol Int. 2022. PMID: 36636161 Free PMC article. No abstract available.
A consensus statement from the Japan Diabetes Society: A proposed algorithm for pharmacotherapy in people with type 2 diabetes.
Bouchi R, Kondo T, Ohta Y, Goto A, Tanaka D, Satoh H, Yabe D, Nishimura R, Harada N, Kamiya H, Suzuki R, Yamauchi T; JDS Committee on Consensus Statement Development. Bouchi R, et al. Among authors: kondo t. J Diabetes Investig. 2023 Jan;14(1):151-164. doi: 10.1111/jdi.13960. Epub 2022 Dec 23. J Diabetes Investig. 2023. PMID: 36562245 Free PMC article. No abstract available.
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
Das Pradhan A, Glynn RJ, Fruchart JC, MacFadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ, Brinton EA, Eckel RH, Elam MB, Felicio JS, Ginsberg HN, Goudev A, Ishibashi S, Joseph J, Kodama T, Koenig W, Leiter LA, Lorenzatti AJ, Mankovsky B, Marx N, Nordestgaard BG, Páll D, Ray KK, Santos RD, Soran H, Susekov A, Tendera M, Yokote K, Paynter NP, Buring JE, Libby P, Ridker PM; PROMINENT Investigators. Das Pradhan A, et al. N Engl J Med. 2022 Nov 24;387(21):1923-1934. doi: 10.1056/NEJMoa2210645. Epub 2022 Nov 5. N Engl J Med. 2022. PMID: 36342113 Clinical Trial.
Phosphatase protector alpha4 (α4) is involved in adipocyte maintenance and mitochondrial homeostasis through regulation of insulin signaling.
Sakaguchi M, Okagawa S, Okubo Y, Otsuka Y, Fukuda K, Igata M, Kondo T, Sato Y, Yoshizawa T, Fukuda T, Yamagata K, Cai W, Tseng YH, Sakaguchi N, Kahn CR, Araki E. Sakaguchi M, et al. Among authors: kondo t. Nat Commun. 2022 Oct 14;13(1):6092. doi: 10.1038/s41467-022-33842-4. Nat Commun. 2022. PMID: 36241662 Free PMC article.
129 results